|
Parameter
|
% traced (95% CI#)
|
Adjusted OR (95% CI)
|
P
|
|---|
|
Gender
| | |
0.34
|
|
Female
|
73.8 (68.9-78.3)
|
1.20 (0.83-1.73)
| |
|
Male
|
73.7 (68.4-78.5)
|
1
| |
|
Age group
| | |
0.11
|
|
15-29
|
63.9 (54.7-72.4)
|
1
| |
|
30-39
|
74.2 (68.7-79.2)
|
1.59 (0.99-2.55)
| |
|
40-49
|
78.5 (72.0-84.1)
|
1.91 (1.12-3.24)
| |
|
≥ 50
|
76.2 (63.8-86.0)
|
1.71 (0.83-3.5)
| |
|
Reason start ART
| | |
0.39
|
|
Low CD4 count
|
72.2 (60.4-82.1)
|
1
| |
|
WHO stage 3
|
73.9 (69.5-77.9)
|
1.15 (0.64-2.04)
| |
|
WHO stage 4
|
71.8 (63.0-79.5)
|
1.07 (0.54-2.12)
| |
|
Other/unknown
|
89.5 (66.9-98.7)
|
3.38 (0.7-16.43)
| |
|
Time of last visit*
| | |
0.94
|
|
No follow-up
|
72.5 (63.1-80.6)
|
1
| |
|
Months 1 to 6
|
71.3 (66.1-76.1)
|
0.95 (0.57-1.57)
| |
|
Months 7 to 12
|
76.9 (66.0-85.7)
|
0.92 (0.45-1.89)
| |
|
Months 13 or later
|
78.7 (71.0-85.2)
|
0.77 (0.34-1.74)
| |
|
Telephone contact
| | |
< 0.001
|
|
None
|
67.0 (61.9-71.9)
|
1
| |
|
Available
|
81.4 (76.6-85.6)
|
2.07 (1.42-3.01)
| |
|
Treatment period
| | |
0.13
|
|
Paying
|
79.5 (73.5-84.6)
|
1.66 (0.85-3.23)
| |
|
Free ART
|
70.9 (66.4-75.1)
|
1
| |
- # binomial exact 95% confidence interval
- *Follow up time from start of ART until last patient visit
